SCHEMBL663312

SCHEMBL663312

COCCCc1cccc(CNC2CC2)c1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.54
POLB P06746 1/20 0.44
CXCR4 P61073 1/20 0.43
KCNH2 Q12809 1/20 0.43
ACHE P22303 2/20 0.42
BACE1 P56817 2/20 0.42
TSHR P16473 1/20 0.41
CARM1 Q86X55 4/20 0.40
PRMT6 Q96LA8 4/20 0.40
PRMT8 Q9NR22 1/20 0.40
GRIN2B Q13224 2/20 0.40
MEN1 O00255 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
PARP1 P09874 1/20 0.39
BCHE P06276 1/20 0.39
GRIN1 Q05586 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1518539 0.88 ALDH1A1 (0.49) ALDH1A1POLBCXCR4ACHEBACE1
SCHEMBL10186619 0.83 ALDH1A1 (0.50) ALDH1A1POLBCXCR4ACHEBACE1
SCHEMBL695510 0.83 ALDH1A1 (0.62) ALDH1A1POLBTSHRCARM1PRMT6
SCHEMBL1518688 0.82 ALDH1A1 (0.44) ALDH1A1POLBCXCR4ACHEBACE1
SCHEMBL1071788 0.81 CNR1 (0.48) ALDH1A1POLBTSHRMEN1KMT2A
SCHEMBL1073181 0.81 ALDH1A1 (0.43) ALDH1A1POLBCXCR4KCNH2ACHE
SCHEMBL1073010 0.81 ALDH1A1 (0.61) ALDH1A1POLBACHEBACE1TSHR
SCHEMBL1074356 0.81 ALDH1A1 (0.43) ALDH1A1POLBCXCR4KCNH2ACHE
SCHEMBL10186621 0.80 ALDH1A1 (0.53) ALDH1A1POLBCXCR4KCNH2ACHE
SCHEMBL1229421 0.79 ALDH1A1 (0.48) ALDH1A1POLBKCNH2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102015682-B 3, 4-substituted piperidine derivatives as renin inhibitors MERCK FROSST CANADA LTD 2014-07-16 CN disclosed
US-20120046293-A1 RENIN INHIBITORS MERCK FROSST CANADA LTD. (CA) 2012-02-23 US disclosed
US-20120046293-A1 RENIN INHIBITORS MERCK FROSST CANADA LTD. (CA) 2012-02-23 US disclosed
US-8063105-B2 Renin inhibitors MERCK CANADA INC. (CA) 2011-11-22 US disclosed
US-8063105-B2 Renin inhibitors MERCK CANADA INC. (CA) 2011-11-22 US disclosed
US-8063105-B2 Renin inhibitors MERCK CANADA INC. (CA) 2011-11-22 US disclosed
US-20090281103-A1 Renin Inhibitors MERCK CANADA INC. (CA) 2009-11-12 US disclosed
US-20090281103-A1 Renin Inhibitors MERCK CANADA INC. (CA) 2009-11-12 US disclosed
US-20090281103-A1 Renin Inhibitors MERCK CANADA INC. (CA) 2009-11-12 US disclosed
EP-1910272-A1 RENIN INHIBITORS Merck Frosst Canada Ltd. (CA) 2008-04-16 EP disclosed
WO-2007009250-A1 RENIN INHIBITORS MERCK FROSST CANADA LTD. (CA) 2007-01-25 WO disclosed
WO-2007009250-A1 RENIN INHIBITORS MERCK FROSST CANADA LTD. (CA) 2007-01-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046293-A1 RENIN INHIBITORS REN, ACE, AGTR1 ALDH1A1 2104/4885POLB 2865/4885CXCR4 4018/4885
US-20090281103-A1 Renin Inhibitors REN, ACE, AGT ALDH1A1 2078/4885POLB 2408/4885CXCR4 4249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.